These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 16320247)
1. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Christacos NC; Quade BJ; Dal Cin P; Morton CC Genes Chromosomes Cancer; 2006 Mar; 45(3):304-12. PubMed ID: 16320247 [TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043 [TBL] [Abstract][Full Text] [Related]
3. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression. Hodge JC; Morton CC Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550 [TBL] [Abstract][Full Text] [Related]
4. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids. Hodge JC; Quade BJ; Rubin MA; Stewart EA; Dal Cin P; Morton CC Am J Pathol; 2008 May; 172(5):1403-10. PubMed ID: 18403592 [TBL] [Abstract][Full Text] [Related]
5. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis. Zahn S; Sievers S; Alemazkour K; Orb S; Harms D; Schulz WA; Calaminus G; Göbel U; Schneider DT Genes Chromosomes Cancer; 2006 Nov; 45(11):995-1006. PubMed ID: 16897744 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma. Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975 [TBL] [Abstract][Full Text] [Related]
7. Microarray-based CGH of sporadic and syndrome-related pheochromocytomas using a 0.1-0.2 Mb bacterial artificial chromosome array spanning chromosome arm 1p. Aarts M; Dannenberg H; deLeeuw RJ; van Nederveen FH; Verhofstad AA; Lenders JW; Dinjens WN; Speel EJ; Lam WL; de Krijger RR Genes Chromosomes Cancer; 2006 Jan; 45(1):83-93. PubMed ID: 16215979 [TBL] [Abstract][Full Text] [Related]
8. Analysis of genomic imprinting at 1p35-36 in neuroblastoma. Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906 [TBL] [Abstract][Full Text] [Related]
10. Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p. Mukasa A; Ueki K; Matsumoto S; Tsutsumi S; Nishikawa R; Fujimaki T; Asai A; Kirino T; Aburatani H Oncogene; 2002 Jun; 21(25):3961-8. PubMed ID: 12037678 [TBL] [Abstract][Full Text] [Related]
11. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity. Hodge JC; Kim TM; Dreyfuss JM; Somasundaram P; Christacos NC; Rousselle M; Quade BJ; Park PJ; Stewart EA; Morton CC Hum Mol Genet; 2012 May; 21(10):2312-29. PubMed ID: 22343407 [TBL] [Abstract][Full Text] [Related]
12. Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies. Gross KL; Panhuysen CI; Kleinman MS; Goldhammer H; Jones ES; Nassery N; Stewart EA; Morton CC Genes Chromosomes Cancer; 2004 Nov; 41(3):183-90. PubMed ID: 15334541 [TBL] [Abstract][Full Text] [Related]
13. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas. Välimäki S; Forsberg L; Farnebo LO; Larsson C Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610 [TBL] [Abstract][Full Text] [Related]
14. Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Bardi G; Pandis N; Fenger C; Kronborg O; Bomme L; Heim S Cancer Res; 1993 Apr; 53(8):1895-8. PubMed ID: 8467511 [TBL] [Abstract][Full Text] [Related]
15. Gene expression profiles associated with treatment response in oligodendrogliomas. French PJ; Swagemakers SM; Nagel JH; Kouwenhoven MC; Brouwer E; van der Spek P; Luider TM; Kros JM; van den Bent MJ; Sillevis Smitt PA Cancer Res; 2005 Dec; 65(24):11335-44. PubMed ID: 16357140 [TBL] [Abstract][Full Text] [Related]
16. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability. Fletcher JA; Morton CC; Pavelka K; Lage JM Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender. Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770 [TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190 [TBL] [Abstract][Full Text] [Related]